Literature DB >> 8353253

Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis.

J M Langley1, J C LeBlanc, J Drake, R Milner.   

Abstract

The objective of this study was to determine if perioperative antimicrobial prophylaxis decreases the incidence of subsequent shunt infection in patients who require placement of internal CSF shunts. Data sources included a computerized search of two biomedical data bases, contact with colleagues, and a review of abstracts of meetings and of references of identified trials and reviews. Studies were chosen for detailed review if they involved human subjects who underwent CSF shunt placement, with random allocation of patients to groups receiving perioperative systemic antimicrobial agents or to a control group and an outcome measure of subsequent shunt infection. Twelve (32%) of 37 studies met selection criteria and were included. Features of trial design were extracted and trial quality was evaluated with use of a predetermined protocol by three independent investigators who were blinded to titles, authors, and institutions. Individually, only one of 12 trials achieved statistical significance favoring prophylaxis; in the aggregate, the use of prophylactic antibiotics was associated with a significant reduction in subsequent CSF shunt infection (Mantel-Haenszel weighted risk ratio: 0.52; 95% confidence interval: 0.37, 0.73; P = .0002; approximate risk reduction: 50%). This systematic overview of 12 trials of 1,359 randomized patients demonstrates that perioperative use of antimicrobial agents in CSF shunt placement significantly reduces the risk of subsequent infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8353253     DOI: 10.1093/clinids/17.1.98

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Hydrocephalus--what's new?

Authors:  P Chumas; A Tyagi; J Livingston
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

Review 2.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

Review 3.  Cost-effective prophylaxis of surgical infections.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

4.  Prophylactic antibiotics in pediatric shunt surgery.

Authors:  N Biyani; G Grisaru-Soen; P Steinbok; S Sgouros; S Constantini
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

Review 5.  Prophylactic antibiotics in pediatric neurological surgery.

Authors:  Friederike Knerlich-Lukoschus; Martina Messing-Jünger
Journal:  Childs Nerv Syst       Date:  2018-06-16       Impact factor: 1.475

6.  Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts.

Authors:  B M Borgbjerg; F Gjerris; M J Albeck; S E Børgesen
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

7.  Infection rate and risk factors associated with infections related to external ventricular drain.

Authors:  E F Camacho; I Boszczowski; M Basso; B C P Jeng; M P Freire; T Guimarães; M J Teixeira; S F Costa
Journal:  Infection       Date:  2011-01-25       Impact factor: 3.553

Review 8.  Antimicrobial prophylaxis in adults.

Authors:  Mark J Enzler; Elie Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

9.  Cerebrospinal Fluid Shunt Infection: Emerging Paradigms in Pathogenesis that Affect Prevention and Treatment.

Authors:  Tamara D Simon; Joshua K Schaffzin; Charles B Stevenson; Kathryn Willebrand; Matthew Parsek; Lucas R Hoffman
Journal:  J Pediatr       Date:  2018-12-06       Impact factor: 4.406

10.  Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children.

Authors:  Henry E Aryan; Hal S Meltzer; Min S Park; Rebecca L Bennett; Rahul Jandial; Michael L Levy
Journal:  Childs Nerv Syst       Date:  2004-10-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.